ArticleMembranes2026
Impedance-Controlled Molecular Transport Across Multilayer Skin Membranes.
Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Analytical models of transdermal drug delivery (TDD) often represent deeper skin layers using ideal sink assumptions or phenomenological interfacial resistances. While mathematically convenient, these approaches obscure the physical role of the dermis and hypodermis in controlling molecular transport. Here, we develop an impedance-based analytical model for diffusion across multilayer skin membranes, in which the epidermal barrier is dynamically coupled to a finite diffusive backing layer representing the dermis-hypodermis composite. Diffusion impedance links transport conductivity, storage capacity, and layer thickness, while preserving continuity of concentration and flux at all interfaces. Closed-form expressions in the Laplace domain describe concentration fields and interfacial fluxes, and cumulative drug uptake is computed in the time domain via inverse Laplace transformation. The model identifies distinct short- and long-time transport regimes. Commonly used Dirichlet and Robin boundary conditions emerge as limiting cases but cannot reproduce the regime-dependent behavior of a backing layer. In particular, Robin formulations reduce the backing layer to a constant effective resistance, neglecting its storage capacity and time-dependent impedance. By replacing ad hoc boundary conditions with a physically grounded impedance framework, this approach provides a unified and extensible method for analyzing multilayer transport systems, including extensions to anomalous or memory-dependent diffusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.